USD10
VSTM Shares
About VerastemVerastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
USD10
VSTM Shares
About VerastemVerastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Stats
TRADING WINDOW
Closed
OPENS AT
Jul 27 at 1:30 PM GMT+0
MARKET CAP
$534.27M
OPEN PRICE
Not enough data
LOW (1Y)
$3.43
HIGH (1Y)
$11.25
LOW (24H)
$6.06
HIGH (24H)
$6.12
VOLUME (24H)
$516.00
99.98%
Price history
Time | Price | Change |
|---|---|---|
Today | Not enough data | Not enough data |
1 Day | $6.12 | |
1 Week | $6.08 | |
1 Month | $3.80 | |
1 Year | $6.02 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
